![Andrew Goldberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Goldberg
Chief Executive Officer at
ACHIEVE LIFE SCIENCES, INC.
Net worth: 1 M $ as of 30/05/2026
Profile
Andrew D.
Goldberg is Chief Executive Officer & Director at Achieve Life Sciences, Inc. since 2026.
Dr. Goldberg is Independent Director at Tarsus Pharmaceuticals, Inc. since 2020.
Former roles include Chairman at Swift Health Systems, Inc., Director at Ossium Health, Inc., and Vice President & Market Strategist at JPMorgan Investment Management, Inc. from 2002 to 2011.
Education includes undergraduate studies at Bryant University and a doctorate from George Washington University School of Medicine & Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/06/2026 | 19,654 ( 0.05% ) | 1 M $ | 30/05/2026 |
Andrew Goldberg active positions
| Companies | Position | Start |
|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Director/Board Member | 31/07/2020 |
| ACHIEVE LIFE SCIENCES, INC. | Chief Executive Officer | 17/04/2026 |
Former positions of Andrew Goldberg
| Companies | Position | End |
|---|---|---|
Swift Health Systems, Inc.
 Swift Health Systems, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which develops invisible orthodontic solutions | Chairman | - |
Ossium Health, Inc.
 Ossium Health, Inc. BiotechnologyHealth Technology Develops first-of-its-kind solution for processing, banking and deploying bone marrow derived cell therapies | Director/Board Member | - |
JPMorgan Investment Management, Inc.
 JPMorgan Investment Management, Inc. Investment ManagersFinance JPMIM seeks to generate positive excess return through both a bottom-up approach emphasizing security selection and a top-down approach focusing on macro investment themes and trends to aid in determining sector weightings, currency, and yield curve weighting where appropriate. The firm offers a broad range of US, non-US and global investment management products and provides different strategies that span the full spectrum of asset classes including equity, fixed-income, cash liquidity, currency, real estate, hedge funds and private equity. | Market Strategist | - |
Training of Andrew Goldberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
JPMorgan Investment Management, Inc.
JPMorgan Investment Management, Inc. Investment ManagersFinance JPMIM seeks to generate positive excess return through both a bottom-up approach emphasizing security selection and a top-down approach focusing on macro investment themes and trends to aid in determining sector weightings, currency, and yield curve weighting where appropriate. The firm offers a broad range of US, non-US and global investment management products and provides different strategies that span the full spectrum of asset classes including equity, fixed-income, cash liquidity, currency, real estate, hedge funds and private equity. | Finance |
Bryant University
 Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swift Health Systems, Inc.
Swift Health Systems, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which develops invisible orthodontic solutions | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
George Washington University School of Medicine & Health
 George Washington University School of Medicine & Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ossium Health, Inc.
Ossium Health, Inc. BiotechnologyHealth Technology Develops first-of-its-kind solution for processing, banking and deploying bone marrow derived cell therapies | Health Technology |
Tarsus Pharmaceuticals, Inc.
 Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis | Health Technology |
- Stock Market
- Insiders
- Andrew Goldberg
